2021 vaccines for adults
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30121D11353
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2021 Vaccines For Adults (VFA) Solicitation · 75D30121R71940 · Posted Apr 5, 2021
- 2021 Vaccines For Adults (VFA) Award Notice · Posted Jul 7, 2021
- Last date to order 100% complete
- IDV ceiling
- $156,027,900.00
- Maximum order
- $155,989,350.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC to procure a variety of adult vaccines over a 1-year period from July 1, 2021 to June 30, 2022. The $156,027,900 multiple award IDC contains no set-aside designation and requires delivery within 15 business days of order placement to destinations across the United States to support state health departments and immunization programs. The original solicitation sought 13 different vaccine types including hepatitis, pneumococcal, tetanus/diphtheria, herpes zoster, measles/mumps/rubella, meningococcal, HPV, varicella, and pneumococcal conjugate, with minimum and maximum order quantities specified. Glaxosmithkline has also received other federal IDV awards from agencies like the VA and DLA to supply seasonal influenza vaccines, vaccine storage services, and the antiviral medication zanamivir, demonstrating the company's extensive experience providing pharmaceutical products and services to the U.S. government.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$340 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $4,836,944 | |
| Funding Only Action | $692,217 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $4,780,121 | |
| Funding Only Action | $4,494,827 | |
| Original award | $3,275,042 |
Quick answers
Who was awarded contract 75D30121D11353?
75D30121D11353 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 25, 2021.
How much is contract 75D30121D11353 worth?
75D30121D11353's own ceiling is $156,027,900. A single order can be worth up to $155,989,350.
Who can order from contract 75D30121D11353?
75D30121D11353 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30121D11353 competed?
The extent of competition for 75D30121D11353 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV